New Clinical Results from RheOx(TM) System for Chronic Bronchitis to be Presented at European Respiratory Society (ERS) International Congress
MENLO PARK, Calif., Sept. 26, 2019 -- (Healthcare Sales & Marketing Network) -- Gala Therapeutics, Inc. (Gala), a developer of medical devices to treat pulmonary disease, today announced that clinical results and a patient case involving its RheOxTM Bronc... Devices Gala Therapeutics, RheOx system, Bronchial Rheoplasty, Chronic Bronchitis
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Bronchitis | Marketing | Medical Devices | Men | Pharmaceuticals | Politics | Respiratory Medicine